The chemotherapy of rodent malaria. LXIII. Drug combinations to impede the selection of drug resistance, part 6: the potential value of chlorproguanil and dapsone in combination, and with the addition of artesunate-Reference-Cited by-同舟云学术

The chemotherapy of rodent malaria. LXIII. Drug combinations to impede the selection of drug resistance, part 6: the potential value of chlorproguanil and dapsone in combination, and with the addition of artesunate

Published:2005-07 Issue:5 Volume:99 Page:457-472
ISSN:0003-4983
Container-title:Annals of Tropical Medicine & Parasitology
language:en
Short-container-title:Annals of Tropical Medicine & Parasitology

Author:

Peters W.,Stewart L. B.,Robinson B. L.

Publisher

Informa UK Limited

Subject

Infectious Diseases,Parasitology

Link

http://www.tandfonline.com/doi/pdf/10.1179/136485905X51274

Reference30 articles.

1. Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial

2. Chlorproguanil-dapsone: effective treatment for uncomplicated falciparum malaria

3. Artesunate combinations for treatment of malaria: meta-analysis

4. MALARIA IN THE AUSTRALIAN ARMY IN SOUTH VIETNAM SUCCESSFUL USE OF A PROGUANIL‐DAPSONE COMBINATION FOR CHEMOPROPHYLAXIS OF CHLOROQUINE‐RESISTANT FALCIPARUM MALARIA

5. Evaluation of CI-564, a 1:1 Mixture of Cycloguanil Pamoate (CI-501) and 4,4′-Diacetylaminodiphenylsulfone (CI-556), Against Multiresistant Falciparum Malarias

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artesunate and Dihydroartemisinin (DHA): Unusual Decomposition Products Formed under Mild Conditions and Comments on the Fitness of DHA as an Antimalarial Drug;ChemMedChem;2007-10-08

2. A database of antimalarial drug resistance;Malaria Journal;2006-06-15

3. Prospects for the treatment of drug-resistant malaria parasites;Future Microbiology;2006-06

4. Folate metabolism as a source of molecular targets for antimalarials;Future Microbiology;2006-06